The cardiologist's bond has been set at $5 million. He will appear in court next on June 22 for a preliminary hearing.

Multiple medical devices used during cardiopulmonary bypass and extracorporeal membrane oxygenation procedures have been voluntarily recalled due to issues with their packaging.

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

Cedars-Sinai researchers are developing a deep-learning algorithm to personalize patient cardiac risk predictions in a patient-friendly, graphical report.

Pulsed field ablation is one of the biggest technology trends in cardiac electrophysiology and may become a new standard of care in atrial fibrillation the coming years based on clinical data.

The new company formed in 2021, but waited until now to publicly launch. Its founders included two Stanford University physicians.

The device, now on display at TVT 2023 in Phoenix, is scheduled to begin hitting the market in the months ahead. 

An ear clip device has been shown to effectively stimulate nerves to treat postural tachycardia syndrome.

Malissa Wood, MD, co-director of Corrigan Women’s Heart Health Program at Massachusetts General Hospital, shares some of the latest data from the iSCAD Registry.

“It is your firm’s responsibility to ensure compliance with applicable laws and regulations administered by FDA,” according to the warning letter. These issues, the agency added, “may be symptomatic of serious problems in your firm’s manufacturing and quality management systems.”